CSL Limited

ASX (AUD): CSL Limited (CSL)

Last Price

278.45

Today's Change

-0.52 (0.18%)

Day's Change

278.27 - 282.98

Trading Volume

705,115

Overview

Market Cap

134 Billion

Shares Outstanding

483 Million

Avg Volume

720,376

Avg Price (50 Days)

281.55

Avg Price (200 Days)

270.91

PE Ratio

35.34

EPS

7.88

Earnings Announcement

13-Feb-2024

Previous Close

278.97

Open

281.57

Day's Range

278.27 - 282.98

Year Range

228.65 - 312.99

Trading Volume

705,115

Price Change Highlight

1 Day Change

-0.19%

5 Day Change

3.13%

1 Month Change

-0.89%

3 Month Change

-4.44%

6 Month Change

17.37%

Ytd Change

-3.42%

1 Year Change

-8.51%

3 Year Change

2.47%

5 Year Change

42.79%

10 Year Change

309.85%

Max Change

33569.89%

News and Blogs

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and CSL Seqirus. The CSL Behring segment offers plasma therapies, such as plasma products and recombinants. This segment also conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The CSL Seqirus segment manufactures and distributes non-plasma biotherapeutic products; and develops influenza related products. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment